UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| | | |
| Date of Report (Date of Earliest Event Reported): | | June 22, 2005 |
Hythiam, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| | | |
| Delaware | 333-58246 | 88-0464853 |
_____________________
(State or other jurisdiction | _____________
(Commission | ______________
(I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| | | |
| 11150 Santa Monica Boulevard, Suite 1500, Los Angeles, California | | 90025 |
_________________________________
(Address of principal executive offices) | | ___________
(Zip Code) |
| | | |
| Registrant’s telephone number, including area code: | | (310) 444-4300 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On June 22, 2005, Hythiam, Inc. and its wholly-owned subsidiary, Hythiam International (Cayman) Ltd., entered into an asset purchase agreement with Dr. Jacob Hiller to obtain the worldwide rights to his trade secret protocols for the treatment of nicotine and drug dependence, in exchange for a percentage of future net profits from exploitation of the protocols. In addition, as part of the company's European expansion strategy, Hythiam International (Cayman) Ltd. purchased the operating assets of Dr. Hiller’s clinic in Valencia, Spain, and its wholly-owned subsidiary, Hythiam International Sàrl, is taking over the clinic operations and is engaging Dr. Hiller as a consultant. There is no material relationship between the registrant or its affiliates and Dr. Hiller, other than in respect of the agreements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | Hythiam, Inc. |
| | | | | |
| June 23, 2005 | | By: | | /s/ Chuck Timpe
|
| | | | |
|
| | | | | Name: Chuck Timpe |
| | | | | Title: Chief Financial Officer |
